CASC2 and miR-155 as Biomarkers in Lupus Nephritis
Author Information
Author(s): Mohamed Nada R., El-Fattah Abeer l. Abd, Shaker Olfat, Sayed Ghadir A
Primary Institution: Egyptian Russian University
Hypothesis
This research investigates lncRNA CASC2 and miR-155 levels as non-invasive diagnostic biomarkers in SLE patients, including those with and without nephritis.
Conclusion
Both lncRNA CASC2 and miR-155 could serve as valuable non-invasive diagnostic biomarkers for SLE and predicting lupus nephritis.
Supporting Evidence
- Increased levels of lncRNA CASC2 were observed in SLE patients compared to healthy controls.
- Elevated expression of lncRNA CASC2 was correlated with the severity of the disease.
- MiR-155 was down-regulated in SLE patients relative to controls.
Takeaway
This study found that two molecules in the blood can help doctors tell if someone has a serious kidney problem related to lupus.
Methodology
The study involved measuring lncRNA CASC2 and miR-155 levels in serum samples from SLE patients and healthy controls using real-time PCR.
Limitations
The modest sample size may constrain the statistical power of the study.
Participant Demographics
60 SLE patients aged 18-60, including 30 with lupus nephritis and 30 without, plus 30 healthy controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website